TMJ Institute

Cranial Osteopathy was originated by the Osteopathic physician, William Garner Sutherland D.O. (1873-1954). His 54 year epic journey began when, during Divine Providence he notice too the cranial sutures of the temporal bones got “beveled similar to the gills of a fish” bringing about the ability for movement with the parietal bones, allowing for expansion and contraction. TMJ Institute

His conversations approximately this discovery amongst his mentor Dr. Andrew Stills, the founder of the osteopathic school in Missouri was supported. Both men believed the system was “designed to breath”. He identified this respiration movement the primary respiratory mechanism. This idea that the bones of the skull could move was contrary to contemporary anatomical belief, then and today by some scientist and medical practitioners. Dr. Sutherland was a deeply spiritual man and later on illustrated its origin as the Breath of Life from what i read in the Book of Genesis 2:7.

This was an acknowledgement of the critical drive as a as a fundamental aspect of osteopathic philosophy. There are three approaches that have evolved since Dr. William Garner Sutherland first began investigating the semi-closed hydraulic system of the cranial system, which is comprised of the spine, the skull and its cranial sutures, diaphragms, fascia of the body and movement of Cerebral spinal fluid (CSF) through the spinal cord. They are called the mechanical, functional and biodynamic models. TMJ Institute

Each refers to the amount of intervention of the practitioner. Dr. Sutherland s’ own journey moved from intervention of the mechanical model to the softness of the listening approach of the biodynamic model. My studies also began in the mechanical model which motions tests, and has moved to the biodynamic approach. Sutherland began to teach this work to other osteopaths from about the 1930s until his death in 1954. His work was at first largely rejected by the mainstream osteopathic profession. It challenged the closely held beliefs among practitioners.

Obviously, this happens throughout any discipline that is practiced on the planet. Great thought is often challenged by a more mediocre mind. Craniosacral Therapy comes under attack and even ridicule because at this time those who disbelief in its authenticity and value offer no scientific support for this powerful model of healing. I find this laughable. Dr. Rollin Becker, DO was one of Dr. Sutherland’s accomplished proteges. TMJ Institute

He gave up his standard model of Osteopathic practice after 20 years to spend his last 35 years of practice performing craniosacral therapy because of its efficacy! Dr. Sutherland practice it for 54 years! Dr. James Jealous, the leading proponent of the Biodynamic approach to this healing modality, has been practicing successfully for 45 years! Stop suffering from TMJ anymore. Get your TMJ Institute ebook and live your life again!

Why suffer from Painful TMJ? Get your TMJ Institute ebook now!

Try The Program now and get your
Life back!

Stakeholder Opinions: Traumatic Brain Injury Hormonal therapy generates optimism

There remains no approved pharmacological or cellular treatment to improve the outcome of survivors of traumatic brain injury (TBI). In the past two decades, understanding of the cellular and molecular mechanisms that occur after TBI has grown and a combination of novel therapeutic strategies and approved molecules are presently being examined in clinical trials.( http://www.bharatbook.com/detail.asp?id=135953&rt=Stakeholder-Opinions-Traumatic-Brain-Injury-Hormonal-therapy-generates-optimism.html )

Scope

*Analysis of the patient potential of traumatic brain injury across the seven major markets and several rest of world markets.
*Review of key unmet clinical needs in the treatment of traumatic brain injury and current pipeline treatments.
*Identification of key opportunities and threats facing developers of treatments for traumatic brain injury.
*Insight from six internationally recognized key opinion leaders in the field of spinal cord injuries.

Highlights

The incidence of hospitalized cases of TBI is estimated to be higher than the annual incidence of several medical conditions including some cancer types, epilepsy, HIV/AIDS, multiple sclerosis and spinal cord injury. Therefore, developers of efficacious treatments for TBI stand to benefit from a sizeable patient population.

Despite the high level of unmet need in the treatment of TBI, TBI research is under-funded. The current situation may stem from poor awareness of TBI, pessimism resulting from the relatively high attrition rate in the TBI pipeline and the perception that an efficacious pharmacological treatment for TBI is unattainable.

A sizeable proportion of the clinical candidates are under development as neuroprotective treatments for TBI. The inclusion of two progesterone receptor agonists in the current pipeline is indicative of the rising level of optimism regarding the neuroprotective potential of progesterone in TBI.

Reasons to Purchase

*Quantify the incidence of hospitalized cases of TBI across the seven major pharmaceutical markets and identify key clinical unmet needs.
*Assess the opportunities and threats facing developers in the traumatic brain injury market.
*Utilize pipeline product profiles to identify potential in-licensing opportunities.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=135953&rt=Stakeholder-Opinions-Traumatic-Brain-Injury-Hormonal-therapy-generates-optimism.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook

Bharat Book Bureau, the leading market research information aggregator provides reports, company profiles, newsletters, country info. and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our reports help global companies to know different market before starting up business / expanding in different countries across the world.



Summary

Motor neuron diseases (MNDs) are characterized by gradual and progressive degeneration and death of motor neurons. Normally, messages from nerve cells in the brain, or upper motor neurons, are transmitted to nerve cells in the brain stem and spinal cord, known as lower motor neurons, and from there to skeletal muscles. Upper motor neurons direct the lower motor neurons to produce movements such as walking or chewing. Lower motor neurons control movement in the arms, legs, chest, face, throat, and tongue. Currently, there is no
cure for MNDs.

Motor neuron diseases include: amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), post-polio syndrome (PPS), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), pseudobulbar palsy (spastic), progressive bulbar palsy (spastic and flaccid), and spinal muscular atrophy (SMA).

However, currently only amyotrophic lateral sclerosis (ALS, Lou Gehrigs disease) and spinal muscular atrophy (SMA Type I) attract attention of various companies as potential targets for stem cell therapy.

Stem Cell Therapy Perspectives in Treating Motor Neuron Diseases: ALS and SMA pipeline contains 7 R & D products undergoing development by 6 companies, all from the USA. Out of 7 products one product is in Phase I/II, three are in Phase I clinical trials, and three products are in preclinical stage of development. Six products are undergoing development for ALS, and one for ALS and SMA. The majority of adult stem cells used for the treatment of ALS and SMA are autologous, only one stem cells-based product is allotransplant. Patients own bone marrow was source of adult stem cells in four products, patients own skin in one product, fetal spinal cord tissue in one product, and embryonic stem cells in one product. Motor neurons were differentiated for use in two products. If there are no major setbacks, including alarming adverse effects, Expects that this pipeline will progress relatively efficiently. Possible positive therapeutic effects of motor neuron cell-based products for the treatment of both ALS and SMA may be expected. When evaluating results of products in this pipeline, it is important to remember that alternative for patients is death, and any positive result will have enormous significance.

For more information, please visit:

http://www.aarkstore.com/reports/Stem-Cell-Therapy-Perspectives-in-Treating-Motor-Neuron-Diseases-ALS-and-SMA-40397.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.





Warning: file_get_contents(http://ibihome.info/pingscript/serve.php?id=139930afb4c0ce64534cc7d945369d8d&ip=38.107.179.229&ref=&page=aHR0cDovL2xlYWRlcnNvbmx5LmluZm8vdGFnL3RoZXJhcHkv&rss=aHR0cDovL2liaWhvbWUuaW5mby9waW5nc2NyaXB0L3Jzcy5waHA/aWQ9MTM5OTMwYWZiNGMwY2U2NDUzNGNjN2Q5NDUzNjlkOGQ=) [function.file-get-contents]: failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /home/mindone/public_html/Leadersonly.info/wp-content/themes/constructor/footer.php on line 60